- Home
- / Hookipa Pharma
Hookipa Pharma
Stock Price
$3.7
2024-10-29
Market Capitalization
$36.9 M
2024-10-29
Revenue
$43.9 M
FY, 2024
Hookipa Pharma Summary
Company Summary
- Overview
- Hookipa Pharma develops prophylactic and therapeutic vaccines for the prevention and treatment of multiple infectious diseases and cancer. The company provides a proprietary technology platform, VaxwaveTM, that introduces an approach to vaccination by providing long lasting and potent stimulation of both cellular and humoral immunity.
- Type
- Public
- Status
- Active
- Founded
- 2011
- HQ
- Wien, AT | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
2 locations detected
Wien, Wien HQ
Austria
Helmut-Qualtinger-Gasse 2
New York, NY
United States
350 5th Ave #7240
Hookipa Pharma Financials
Summary Financials
- Revenue (Q1, 2025)
- $2.0M
- Net income (Q1, 2025)
- ($15.4M)
- Cash (Q1, 2025)
- $40.3M
- EBIT (Q1, 2025)
- ($17.9M)
- Enterprise value
- ($2.8M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026